8A3J image
Deposition Date 2022-06-08
Release Date 2022-10-05
Last Version Date 2024-11-20
Entry Detail
PDB ID:
8A3J
Keywords:
Title:
X-ray crystal structure of a de novo designed antiparallel coiled-coil heterotetramer with 3 heptad repeats, apCC-Tet*3-A2B2
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:apCC-Tet*3-A
Chain IDs:A, C, E, G
Chain Length:25
Number of Molecules:4
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:apCC-Tet*3-B
Chain IDs:B, D, F, H
Chain Length:25
Number of Molecules:4
Biological Source:synthetic construct
Primary Citation
From peptides to proteins: coiled-coil tetramers to single-chain 4-helix bundles.
Chem Sci 13 11330 11340 (2022)
PMID: 36320580 DOI: 10.1039/d2sc04479j

Abstact

The design of completely synthetic proteins from first principles-de novo protein design-is challenging. This is because, despite recent advances in computational protein-structure prediction and design, we do not understand fully the sequence-to-structure relationships for protein folding, assembly, and stabilization. Antiparallel 4-helix bundles are amongst the most studied scaffolds for de novo protein design. We set out to re-examine this target, and to determine clear sequence-to-structure relationships, or design rules, for the structure. Our aim was to determine a common and robust sequence background for designing multiple de novo 4-helix bundles. In turn, this could be used in chemical and synthetic biology to direct protein-protein interactions and as scaffolds for functional protein design. Our approach starts by analyzing known antiparallel 4-helix coiled-coil structures to deduce design rules. In terms of the heptad repeat, abcdefg -i.e., the sequence signature of many helical bundles-the key features that we identify are: a = Leu, d = Ile, e = Ala, g = Gln, and the use of complementary charged residues at b and c. Next, we implement these rules in the rational design of synthetic peptides to form antiparallel homo- and heterotetramers. Finally, we use the sequence of the homotetramer to derive in one step a single-chain 4-helix-bundle protein for recombinant production in E. coli. All of the assembled designs are confirmed in aqueous solution using biophysical methods, and ultimately by determining high-resolution X-ray crystal structures. Our route from peptides to proteins provides an understanding of the role of each residue in each design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures